Suppr超能文献

应激与成瘾:促肾上腺皮质激素释放因子(CRF)系统在神经可塑性中的作用。

Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity.

机构信息

Ernest Gallo Clinic and Research Center at the University of California San Francisco Emeryville, CA, USA.

出版信息

Front Mol Neurosci. 2012 Sep 6;5:91. doi: 10.3389/fnmol.2012.00091. eCollection 2012.

Abstract

Corticotropin releasing factor (CRF) has been shown to induce various behavioral changes related to adaptation to stress. Dysregulation of the CRF system at any point can lead to a variety of psychiatric disorders, including substance use disorders (SUDs). CRF has been associated with stress-induced drug reinforcement. Extensive literature has identified CRF to play an important role in the molecular mechanisms that lead to an increase in susceptibility that precipitates relapse to SUDs. The CRF system has a heterogeneous role in SUDs. It enhances the acute effects of drugs of abuse and is also responsible for the potentiation of drug-induced neuroplasticity evoked during the withdrawal period. We present in this review the brain regions and circuitries where CRF is expressed and may participate in stress-induced drug abuse. Finally, we attempt to evaluate the role of modulating the CRF system as a possible therapeutic strategy for treating the dysregulation of emotional behaviors that result from the acute positive reinforcement of substances of abuse as well as the negative reinforcement produced by withdrawal.

摘要

促肾上腺皮质释放因子(CRF)已被证明能诱导与应激适应相关的各种行为变化。CRF 系统在任何时候的失调都可能导致各种精神障碍,包括物质使用障碍(SUD)。CRF 与应激诱导的药物强化有关。大量文献表明,CRF 在导致易感性增加的分子机制中发挥重要作用,从而导致 SUD 的复发。CRF 系统在 SUD 中具有异质性作用。它增强了滥用药物的急性效应,还负责增强戒断期间诱发的药物诱导的神经可塑性。我们在这篇综述中介绍了表达 CRF 的大脑区域和回路,它们可能参与了应激诱导的药物滥用。最后,我们试图评估调节 CRF 系统作为一种可能的治疗策略的作用,以治疗急性正性强化物质滥用以及戒断产生的负性强化所导致的情绪行为失调。

相似文献

1
Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity.
Front Mol Neurosci. 2012 Sep 6;5:91. doi: 10.3389/fnmol.2012.00091. eCollection 2012.
3
Stress, corticotropin-releasing factor, and drug addiction.
Ann N Y Acad Sci. 1999;897:27-45. doi: 10.1111/j.1749-6632.1999.tb07876.x.
4
Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention.
CNS Drugs. 2011 Apr;25(4):271-87. doi: 10.2165/11587790-000000000-00000.
5
Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.
Int Rev Neurobiol. 2017;136:5-51. doi: 10.1016/bs.irn.2017.06.004. Epub 2017 Aug 7.
6
Neurobiological substrates for the dark side of compulsivity in addiction.
Neuropharmacology. 2009;56 Suppl 1(Suppl 1):18-31. doi: 10.1016/j.neuropharm.2008.07.043. Epub 2008 Aug 7.
7
Role of corticotropin-releasing factor and corticosterone in behavioral sensitization to ethanol.
J Pharmacol Exp Ther. 2012 May;341(2):455-63. doi: 10.1124/jpet.111.190595. Epub 2012 Feb 14.
8
Corticotropin releasing factor and neuroplasticity in cocaine addiction.
Life Sci. 2010 Jan 2;86(1-2):1-9. doi: 10.1016/j.lfs.2009.11.005. Epub 2009 Nov 13.
9
Neurocircuitry of alcohol addiction: synthesis from animal models.
Handb Clin Neurol. 2014;125:33-54. doi: 10.1016/B978-0-444-62619-6.00003-3.
10
Role of withdrawal in reinstatement of morphine-conditioned place preference.
Psychopharmacology (Berl). 2005 Aug;181(1):90-100. doi: 10.1007/s00213-005-2207-5. Epub 2005 Oct 15.

引用本文的文献

2
The Impact of Heroin Self-Administration and Environmental Enrichment on Ventral Tegmental CRF1 Receptor Expression.
Int J Neuropsychopharmacol. 2023 Dec 18;26(12):828-839. doi: 10.1093/ijnp/pyad060.
4
Cross-talk between the HPA axis and addiction-related regions in stressful situations.
Heliyon. 2023 Apr 17;9(4):e15525. doi: 10.1016/j.heliyon.2023.e15525. eCollection 2023 Apr.
5
Sleep Deprivation Induces Dopamine System Maladaptation and Escalated Corticotrophin-Releasing Factor Signaling in Adolescent Mice.
Mol Neurobiol. 2023 Jun;60(6):3190-3209. doi: 10.1007/s12035-023-03258-2. Epub 2023 Feb 23.
6
8
Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies.
Neuropsychopharmacology. 2022 Nov;47(12):2111-2122. doi: 10.1038/s41386-022-01363-9. Epub 2022 Jun 27.
9
The Effects of E-Cigarette Use on Alcohol and Marijuana Abuse Symptoms in an Ethnically Diverse Sample of Young Adults.
Int J Environ Res Public Health. 2021 Dec 14;18(24):13159. doi: 10.3390/ijerph182413159.

本文引用的文献

1
Effects of corticotropin-releasing factor 1 receptor antagonism on the hypothalamic-pituitary-adrenal axis of rodents.
J Pharmacol Exp Ther. 2012 Jun;341(3):672-80. doi: 10.1124/jpet.111.189753. Epub 2012 Mar 8.
3
Chronic intermittent ethanol and withdrawal differentially modulate basolateral amygdala AMPA-type glutamate receptor function and trafficking.
Neuropharmacology. 2012 Jun;62(7):2430-9. doi: 10.1016/j.neuropharm.2012.02.017. Epub 2012 Feb 22.
4
Inactivation of the central nucleus of the amygdala reduces the effect of punishment on cocaine self-administration in rats.
Eur J Neurosci. 2012 Mar;35(5):775-83. doi: 10.1111/j.1460-9568.2012.08000.x. Epub 2012 Feb 6.
5
Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view.
Neuropsychopharmacology. 2012 Jan;37(1):308-9. doi: 10.1038/npp.2011.213.
6
The dopamine hypothesis of drug addiction and its potential therapeutic value.
Front Psychiatry. 2011 Nov 29;2:64. doi: 10.3389/fpsyt.2011.00064. eCollection 2011.
8
Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems.
Physiol Behav. 2012 Apr 12;106(1):58-64. doi: 10.1016/j.physbeh.2011.11.004. Epub 2011 Nov 12.
9
Mifepristone in the central nucleus of the amygdala reduces yohimbine stress-induced reinstatement of ethanol-seeking.
Neuropsychopharmacology. 2012 Mar;37(4):906-18. doi: 10.1038/npp.2011.268. Epub 2011 Nov 2.
10
Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1.
Science. 2011 Sep 30;333(6051):1903-7. doi: 10.1126/science.1202107. Epub 2011 Sep 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验